Alexander Khoruts
#161,059
Most Influential Person Now
Researcher ORCID ID = 0000-0002-3205-3188
Alexander Khoruts's AcademicInfluence.com Rankings
Alexander Khorutsphilosophy Degrees
Philosophy
#9291
World Rank
#12829
Historical Rank
Logic
#6274
World Rank
#7779
Historical Rank
Alexander Khorutsbiology Degrees
Biology
#12761
World Rank
#16259
Historical Rank
Microbiology
#761
World Rank
#837
Historical Rank
Download Badge
Philosophy Biology
Why Is Alexander Khoruts Influential?
(Suggest an Edit or Addition)Alexander Khoruts's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- CD4+ T Cell Depletion during all Stages of HIV Disease Occurs Predominantly in the Gastrointestinal Tract (2004) (1918)
- Visualizing the generation of memory CD4 T cells in the whole body (2001) (1113)
- Treating Clostridium difficile infection with fecal microbiota transplantation. (2011) (873)
- Microbiota Transfer Therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: an open-label study (2017) (808)
- Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections. (2008) (657)
- In Vivo Detection of Dendritic Cell Antigen Presentation to CD4+ T Cells (1997) (622)
- Standardized Frozen Preparation for Transplantation of Fecal Microbiota for Recurrent Clostridium difficile Infection (2012) (617)
- Changes in the Composition of the Human Fecal Microbiome After Bacteriotherapy for Recurrent Clostridium difficile-associated Diarrhea (2009) (617)
- Fecal microbiota transplantation and emerging applications (2012) (590)
- Persistent HIV-1 replication is associated with lower antiretroviral drug concentrations in lymphatic tissues (2014) (560)
- Fecal Microbiota Transplant for Treatment of Clostridium difficile Infection in Immunocompromised Patients (2014) (558)
- Circulating tumor necrosis factor, interleukin‐1 and interleukin‐6 concentrations in chronic alcoholic patients (1991) (540)
- In vivo activation of antigen-specific CD4 T cells. (2001) (528)
- Generation of Anergic and Potentially Immunoregulatory CD25+CD4 T Cells In Vivo After Induction of Peripheral Tolerance with Intravenous or Oral Antigen1 (2001) (475)
- Naïve and Memory CD4+ T Cell Survival Controlled by Clonal Abundance (2006) (389)
- Microbiota transplantation restores normal fecal bile acid composition in recurrent Clostridium difficile infection. (2014) (349)
- CTLA-4 blockade reverses CD8+ T cell tolerance to tumor by a CD4+ T cell- and IL-2-dependent mechanism. (1999) (332)
- Understanding the mechanisms of faecal microbiota transplantation (2016) (327)
- Interaction of gut microbiota with bile acid metabolism and its influence on disease states (2016) (313)
- Inflammatory cytokines enhance the in vivo clonal expansion and differentiation of antigen-activated CD4+ T cells. (1997) (309)
- Effect of Fecal Microbiota Transplantation on Recurrence in Multiply Recurrent Clostridium difficile Infection (2016) (308)
- Defining total-body AIDS-virus burden with implications for curative strategies (2017) (279)
- A Natural Immunological Adjuvant Enhances T Cell Clonal Expansion through a CD28-dependent, Interleukin (IL)-2–independent Mechanism (1998) (271)
- High-throughput DNA sequence analysis reveals stable engraftment of gut microbiota following transplantation of previously frozen fecal bacteria (2013) (269)
- Direct evidence that functionally impaired CD4+ T cells persist in vivo following induction of peripheral tolerance. (1998) (251)
- Use of adoptive transfer of T‐cell antigen‐receptor‐transgenic T cells for the study of T‐cell activation in vivo (1997) (246)
- Strain Tracking Reveals the Determinants of Bacterial Engraftment in the Human Gut Following Fecal Microbiota Transplantation. (2018) (243)
- The anatomy of T-cell activation and tolerance. (1996) (229)
- Large number of rebounding/founder HIV variants emerge from multifocal infection in lymphatic tissues after treatment interruption (2015) (227)
- Dynamic changes in short- and long-term bacterial composition following fecal microbiota transplantation for recurrent Clostridium difficile infection (2015) (225)
- From stool transplants to next-generation microbiota therapeutics. (2014) (177)
- Inflammatory Bowel Disease Affects the Outcome of Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection. (2016) (174)
- Collagen deposition limits immune reconstitution in the gut. (2008) (149)
- Competition for self ligands restrains homeostatic proliferation of naive CD4 T cells (2003) (144)
- A causal link between lymphopenia and autoimmunity (2004) (143)
- Neuroantigen-specific Th2 cells are inefficient suppressors of experimental autoimmune encephalomyelitis induced by effector Th1 cells. (1995) (141)
- De novo induction of antigen‐specific CD4+CD25+Foxp3+ regulatory T cells in vivo following systemic antigen administration accompanied by blockade of mTOR (2008) (128)
- Homeostatic Expansion Occurs Independently of Costimulatory Signals1 (2001) (119)
- Stable engraftment of human microbiota into mice with a single oral gavage following antibiotic conditioning (2017) (116)
- Changes in Colonic Bile Acid Composition following Fecal Microbiota Transplantation Are Sufficient to Control Clostridium difficile Germination and Growth (2016) (115)
- Successful Resolution of Recurrent Clostridium difficile Infection using Freeze-Dried, Encapsulated Fecal Microbiota; Pragmatic Cohort Study (2017) (112)
- Changes in microbial ecology after fecal microbiota transplantation for recurrent C. difficile infection affected by underlying inflammatory bowel disease (2017) (108)
- Cystic Fibrosis Colorectal Cancer Screening Consensus Recommendations. (2017) (101)
- High frequencies of polyfunctional HIV-specific T cells are associated with preservation of mucosal CD4 T cells in bronchoalveolar lavage (2008) (100)
- Species and genus level resolution analysis of gut microbiota in Clostridium difficile patients following fecal microbiota transplantation (2014) (100)
- Antagonistic Roles for CTLA-4 and the Mammalian Target of Rapamycin in the Regulation of Clonal Anergy: Enhanced Cell Cycle Progression Promotes Recall Antigen Responsiveness1 (2001) (93)
- Induction of TGF-β1 and TGF-β1–dependent predominant Th17 differentiation by group A streptococcal infection (2010) (91)
- Single-cell analysis of signal transduction in CD4 T cells stimulated by antigen in vivo (2001) (90)
- Oral tolerance in disease (1999) (89)
- Complete Microbiota Engraftment Is Not Essential for Recovery from Recurrent Clostridium difficile Infection following Fecal Microbiota Transplantation (2016) (88)
- Ursodeoxycholic Acid Inhibits Clostridium difficile Spore Germination and Vegetative Growth, and Prevents the Recurrence of Ileal Pouchitis Associated With the Infection (2016) (86)
- Therapeutic transplantation of the distal gut microbiota (2011) (86)
- Resolution of severe Clostridium difficile infection following sequential fecal microbiota transplantation. (2013) (84)
- Microbiota changes and Intestinal Microbiota Transplantation in Liver Diseases and Cirrhosis. (2020) (84)
- Antigen-Experienced CD4 T Cells Display a Reduced Capacity for Clonal Expansion In Vivo That Is Imposed by Factors Present in the Immune Host1 (2000) (77)
- Regulatory CD4+CD25+Foxp3+ T Cells Selectively Inhibit the Spontaneous Form of Lymphopenia-Induced Proliferation of Naive T Cells1 (2008) (71)
- MHC class II deprivation impairs CD4 T cell motility and responsiveness to antigen-bearing dendritic cells in vivo (2007) (68)
- Predicting recurrence of Clostridium difficile infection following encapsulated fecal microbiota transplantation (2018) (67)
- Treatment of recurrent Clostridium difficile infection using fecal microbiota transplantation in patients with inflammatory bowel disease (2017) (67)
- A Role for CD28 in Lymphopenia-Induced Proliferation of CD4 T Cells1 (2004) (64)
- Microbial Exposure Enhances Immunity to Pathogens Recognized by TLR2 but Increases Susceptibility to Cytokine Storm through TLR4 Sensitization. (2019) (63)
- Faecal microbiota transplantation for Clostridioides difficile: mechanisms and pharmacology (2020) (63)
- Colorectal cancer mutational profiles correlate with defined microbial communities in the tumor microenvironment (2018) (58)
- Sensing of ATP via the Purinergic Receptor P2RX7 Promotes CD8+ Trm Cell Generation by Enhancing Their Sensitivity to the Cytokine TGF-β. (2020) (56)
- Guidance on preparing an investigational new drug application for fecal microbiota transplantation studies. (2014) (56)
- Successful Resolution of Recurrent Clostridium Difficile Infection using Freeze-Dried, Encapsulated Fecal Microbiota (2017) (54)
- Functional Genomics of Host-Microbiome Interactions in Humans. (2018) (53)
- A pilot study of fecal bile acid and microbiota profiles in inflammatory bowel disease and primary sclerosing cholangitis (2019) (53)
- Microbiota‐Driven Activation of Intrahepatic B Cells Aggravates NASH Through Innate and Adaptive Signaling (2021) (52)
- Interactions between the gut microbiome and host gene regulation in cystic fibrosis (2019) (49)
- Lymphoid fibrosis occurs in long-term nonprogressors and persists with antiretroviral therapy but may be reversible with curative interventions. (2015) (49)
- Colonoscopic screening shows increased early incidence and progression of adenomas in cystic fibrosis. (2016) (48)
- Durable Long-Term Bacterial Engraftment following Encapsulated Fecal Microbiota Transplantation To Treat Clostridium difficile Infection (2019) (46)
- Fecal Microbiota Transplantation: Current Status in Treatment of GI and Liver Disease (2019) (46)
- High-affinity memory B cells induced by SARS-CoV-2 infection produce more plasmablasts and atypical memory B cells than those primed by mRNA vaccines (2021) (46)
- Development of fecal microbiota transplantation suitable for mainstream medicine. (2015) (44)
- Cost-effectiveness of treatment regimens for Clostridioides difficile infection -an evaluation of the 2018 Infectious Diseases Society of America guidelines. (2019) (43)
- Emergence of fecal microbiota transplantation as an approach to repair disrupted microbial gut ecology. (2014) (42)
- CD4+CD25+Foxp3+ Regulatory T Cells Optimize Diversity of the Conventional T Cell Repertoire during Reconstitution from Lymphopenia (2010) (42)
- IN VIVO ACTIVATION OF ANTIGEN-SPECIFIC (2001) (41)
- Community dynamics drive punctuated engraftment of the fecal microbiome following transplantation using freeze-dried, encapsulated fecal microbiota (2017) (41)
- IL‐1 acts on antigen‐presenting cells to enhance the in vivo proliferation of antigen‐stimulated naive CD4 T cells via a CD28‐dependent mechanism that does not involve increased expression of CD28 ligands (2004) (40)
- Environmental Contamination in Households of Patients with Recurrent Clostridium difficile Infection (2016) (37)
- Early Colon Screening of Adult Patients With Cystic Fibrosis Reveals High Incidence of Adenomatous Colon Polyps (2014) (37)
- Homeostatic Expansion Occurs Independently of Costimulatory Signals (2001) (36)
- Sleeve gastrectomy drives persistent shifts in the gut microbiome. (2017) (35)
- Dysbiosis patterns during re-induction/salvage versus induction chemotherapy for acute leukemia (2019) (30)
- Dietary Factors in Sulfur Metabolism and Pathogenesis of Ulcerative Colitis (2019) (30)
- Fecal Microbiota Transplant in Cirrhosis Reduces Gut Microbial Antibiotic Resistance Genes: Analysis of Two Trials (2020) (29)
- Human microbiome science: vision for the future, Bethesda, MD, July 24 to 26, 2013 (2014) (29)
- Synthesis and Biological Evaluation of Bile Acid Analogues Inhibitory to Clostridium difficile Spore Germination. (2017) (28)
- Targeting the microbiome: from probiotics to fecal microbiota transplantation (2018) (28)
- Human microbiome science: vision for the future, (2014) (27)
- Contemporary Applications of Fecal Microbiota Transplantation to Treat Intestinal Diseases in Humans. (2017) (27)
- Gastric mucosal nerve density (2010) (24)
- Faecal microbiota transplantation is promising but not a panacea (2016) (22)
- Can Intestinal Microbiota and Circulating Microbial Products Contribute to Pulmonary Arterial Hypertension? (2019) (22)
- Analysis of gut microbiota – An ever changing landscape (2017) (22)
- Microbiota transplant therapy and autism: lessons for the clinic (2019) (21)
- Gut dysbiosis during antileukemia chemotherapy versus allogeneic hematopoietic cell transplantation (2019) (21)
- Specific gut microbiota changes heralding bloodstream infection and neutropenic fever during intensive chemotherapy (2019) (20)
- Antibiotic-induced Disruption of Intestinal Microbiota Contributes to Failure of Vertical Sleeve Gastrectomy. (2019) (20)
- Mast Cell Activation Disease and Microbiotic Interactions. (2015) (19)
- Clinician Guide to Microbiome Testing (2018) (18)
- Fecal Microbiota Transplantation is Safe and Effective in Patients with Clostridioides difficile Infection and Cirrhosis. (2020) (18)
- Influence of short-term changes in dietary sulfur on the relative abundances of intestinal sulfate-reducing bacteria (2019) (18)
- Impact of Antibiotic Resistance Genes in Gut Microbiome of Patients with Cirrhosis. (2021) (17)
- Toward revision of antimicrobial therapies in hematopoietic stem cell transplantation: target the pathogens, but protect the indigenous microbiota (2017) (17)
- Stress responses, M2 macrophages, and a distinct microbial signature in fatal intestinal acute graft-versus-host disease. (2019) (16)
- Faecal microbiota transplantation in 2013: Developing human gut microbiota as a class of therapeutics (2014) (16)
- The Impact of Regulatory Policies on the Future of Fecal Microbiota Transplantation (2019) (16)
- Gut microbiota response to antibiotics is personalized and depends on baseline microbiota (2021) (15)
- CLOUD: a non-parametric detection test for microbiome outliers (2018) (14)
- Studying Immunological Tolerance by Physically Monitoring Antigen‐specific T Cells in Vivo a (1996) (13)
- Fecal Microbiota Transplant: A Rose by Any Other Name. (2019) (13)
- Antigen-specific CD4+ T cells that survive after the induction of peripheral tolerance possess an intrinsic lymphokine production defect. (1998) (11)
- Changes in the composition of the human fecal microbiome following bacteriotherapy for recurrent Clostridium difficile-associated diarrhea (2010) (11)
- Probiotics and the Microbiome: How can we help patients make sense of probiotics? (2020) (11)
- Pretransplant Serum Citrulline Predicts Acute Graft-versus-Host Disease. (2018) (11)
- Pre-transplant recovery of microbiome diversity without recovery of the original microbiome (2018) (11)
- Antibiotic-induced Disruption of Intestinal Microbiota Contributes to Failure of Vertical Sleeve Gastrectomy. (2019) (10)
- 7-Methylation of Chenodeoxycholic Acid Derivatives Yields a Substantial Increase in TGR5 Receptor Potency. (2019) (10)
- A model of suppression of the antigen-specific CD4 T cell response by regulatory CD25+CD4 T cells in vivo. (2005) (10)
- Amphiregulin in intestinal acute graft-versus-host disease: a possible diagnostic and prognostic aid (2018) (9)
- Probiotics: promise, evidence, and hope. (2020) (8)
- Is fecal microbiota transplantation a temporary patch for treatment of Clostridium difficile infection or a new frontier of therapeutics? (2018) (7)
- Effect of COVID-19 precautions on the gut microbiota and nosocomial infections (2021) (7)
- Fecal Microbiota Transplantation for Recurrent C difficile Infection During the COVID-19 Pandemic (2021) (7)
- First microbial encounters (2016) (7)
- Stable engraftment of human microbiota into mice with a single oral gavage following antibiotic conditioning (2017) (6)
- Levaquin gets a pass. (2019) (6)
- Gut-sparing treatment of urinary tract infection in patients at high risk of Clostridium difficile infection (2017) (6)
- Peri-operative antibiotics acutely and significantly impact intestinal microbiota following bariatric surgery (2020) (6)
- Vancomycin-resistance gene cluster, vanC, in the gut microbiome of acute leukemia patients undergoing intensive chemotherapy (2019) (6)
- Altered microbiota-host metabolic cross talk preceding neutropenic fever in patients with acute leukemia (2021) (6)
- Intermittent Fasting Enhances Right Ventricular Function in Preclinical Pulmonary Arterial Hypertension. (2021) (5)
- Fecal microbiota transplantation–early steps on a long journey ahead (2017) (5)
- Fecal Microbiota Transplantation: An Interview With Alexander Khoruts (2014) (5)
- Consensus Recommendations for Colorectal Cancer Screening in Adults with Cystic Fibrosis (2017) (5)
- Changes in Microbial Ecology After Fecal Microbiota Transplantation for Recurrent C. Difficile Infection Depends on Underlying Inflammatory Bowel Disease: 2016 ACG Presidential Poster Award: 159 (2016) (4)
- Infection Followed by Graft-versus-Host Disease: Pathogenic Role of Antibiotics. (2017) (4)
- Lasting shift in the gut microbiota in patients with acute myeloid leukemia (2022) (4)
- Lower endoscopic delivery of freeze-dried intestinal microbiota results in more rapid and efficient engraftment than oral administration (2021) (3)
- Can FMT cause or prevent CRC? Maybe, but there is more to consider. (2021) (3)
- Methanogen Abundance Thresholds Capable of Differentiating In Vitro Methane Production in Human Stool Samples (2020) (3)
- Fecal Microbiota Transplantation (FMT) for Treatment of Clostridium difficile Infection (CDI) in Immunocompromised Patients: ACG Governors Award for Excellence in Clinical Research: 611 (2013) (3)
- Fecal microbiota transplantation across the lifespan: balancing efficacy, safety, and innovation. (2022) (3)
- Dynamic changes in short- and long-term bacterial composition following fecal microbiota transplantation for recurrent Clostridium difficile infection (2015) (3)
- Low Amphiregulin Expression in Intestinal Biopsies of Patients with Acute Graft-Versus-Host Disease (2018) (3)
- Case report of synchronous post-lung transplant colon cancers in the era of colorectal cancer screening recommendations in cystic fibrosis: screening “too early” before it’s too late (2019) (3)
- Outpatient-to-Inpatient Transition Causes Marked Dysbiosis in Allogeneic Hematopoietic Cell Transplantation Recipients (2019) (2)
- Effectiveness and safety of colonic and capsule fecal microbiota transplantation for recurrent Clostridioides difficile infection. (2022) (2)
- Gastrointestinal cancers in patients with cystic fibrosis. (2018) (2)
- Differential hydrogen sulfide production by a human cohort in response to animal- and plant-based diet interventions. (2022) (2)
- Tu1769 Short and Long Term Changes in Bacterial Composition Following Fecal Microbiota Transplantation for CDI Visualized in Movie Format (2014) (2)
- Pulmonary Arterial Hypertension Patients Have a Proinflammatory Gut Microbiome and Altered Circulating Microbial Metabolites. (2022) (2)
- Mo1954 – Fecal Microbiota Transplantation is Safe and Effective for the Treatment of Clostridium Difficile Infection in Patients with Liver Cirrhosis (2019) (2)
- A Replicating Single-Cycle Adenovirus Vaccine Effective against Clostridium difficile (2020) (2)
- Reduced Enterohepatic Recirculation of Mycophenolate and Lower Blood Concentrations are Associated with the Stool Bacterial Microbiome After Hematopoietic Cell Transplantation. (2022) (2)
- Multiple bacterial virulence factors focused on adherence and biofilm formation associate with outcomes in cirrhosis (2021) (2)
- Plasma Short Chain Fatty Acids As a Predictor of Response to Therapy for Life-Threatening Acute Graft-Versus-Host Disease (2020) (2)
- Microbiome swings with repeated insults (2020) (2)
- Introduction to special issue on microbiome influences on host immunity. (2014) (2)
- Proliferation of CD 4 T Cells A Role for CD 28 in Lymphopenia-Induced (2004) (2)
- Loss of microbiota-derived protective metabolites after neutropenic fever (2022) (1)
- Su1430 Treatment of C. Difficile by Fecal Transplantation (2012) (1)
- Intestinal microbiota transplantation: Naming a new paradigm. (2020) (1)
- Interactions between the gut microbiome and host gene regulation in cystic fibrosis (2020) (1)
- Convenient Protocol for Production and Purification of Clostridioides difficile Spores for Germination Studies (2020) (1)
- Pre-transplant serum citrulline predicts acute graft-versus-host disease (2018) (1)
- Boosting corrects a memory B cell defect in SARS-CoV-2 mRNA–vaccinated patients with inflammatory bowel disease (2022) (1)
- Stress responses , M 2 macrophages , and a distinct microbial signature in fatal intestinal acute graft-versus-host disease (2019) (1)
- Microbial Therapeutics in Liver Disease (2021) (1)
- Compilation of longitudinal gut microbiome, serum metabolome, and clinical data in acute myeloid leukemia (2022) (1)
- Gut microbiota response to antibiotics is personalized and depends on baseline microbiota (2021) (1)
- Elevated AREG/EGF Ratio Prior to Transplantation Is Associated with Pre-Transplant Clostridium Difficile Infection, Unresolved Tissue Damage, and Poorer Overall Survival (2018) (1)
- Identification of p‐cresol sulfate and secondary bile salts in human urine as sensitive biomarkers of fecal microbiota transplantation in R‐CDI patients (2017) (1)
- Tu1714 Changes in Bacterial Composition Following Fecal Microbiota Transplantation for Severe Clostridium Difficie Infection (2013) (1)
- Fecal β-glucuronidase activity differs between hematopoietic cell and kidney transplantation and a possible mechanism for disparate dose requirements (2022) (1)
- Letter to the Editor. (2019) (1)
- Structural modifications that increase gut restriction of bile acid derivatives. (2021) (1)
- Microbiota Transfer Therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: an open-label study (2017) (1)
- Therapeutic Strategies for Severe and Severe-Complicated Clostridium Difficile Infection (2017) (1)
- Inactivation of Clostridioides Difficile Spores in Carpeting and Upholstery to Reduce Disease Recurrence in Households and Nursing Care Facilities (2021) (0)
- The Vertical Sleeve Gastrectomy is Responsible for Dominant Shifts in Gut Microbiota (2016) (0)
- Su1743 Characterization of Fecal Microbiota in Response to Heterologous Versus Autologous (Placebo) Fecal Microbial Transplantation: Results From a Dual-Center, Randomized, Placebo-Controlled Trial (2016) (0)
- Abstract 10736: Gut Dysbiosis and Altered Circulating Microbial Metabolites in Patients with Pulmonary Arterial Hypertension (2021) (0)
- Circulating bacterial DNA and neutropenic fever during anti‐leukaemia chemotherapy (2020) (0)
- Reply. (2018) (0)
- Predicting recurrence of Clostridium difficile infection following encapsulated fecal microbiota transplantation (2018) (0)
- Fr372 ANTIMICROBIAL RESISTANCE GENES IN GUT MICROBIOTA IMPACT HOSPITALIZATIONS AND DEATH IN PATIENTS WITH CIRRHOSIS AND ARE UNAFFECTED BY RIFAXIMIN THERAPY (2021) (0)
- Species and genus level resolution analysis of gut microbiota in Clostridium difficile patients following fecal microbiota transplantation (2014) (0)
- The role of CTLA-4 in Treg-mediated suppression of T cell LIP (92.6) (2007) (0)
- Mo1862 Diagnostic Value of Colonoscopy in Patients Receiving Fecal Microbiota Transplantation in Treatment of Refractory Clostridium difficile Infection (2015) (0)
- Pre-Transplant Serum Claudin-3 Predicts Intestinal Graft-Versus-Host Disease and Non-Relapse Mortality Risk after Allogeneic Hematopoietic Cell Transplantation. (2019) (0)
- Mo1966 The Gut Microbiome Shifts Acutely and Independently From Hypocaloric Restriction Following the Vertical Sleeve Gastrectomy (2016) (0)
- CLOUD: a non-parametric detection test for microbiome outliers (2018) (0)
- Postoperative Disruption of Intestinal Microbiota Composition Attenuates the Metabolic Efficacy of Vertical Sleeve Gastrectomy (2017) (0)
- Fecal Microbiota Transplantation for Fulminant Clostridioides Difficile Infection: A Combined Medical and Surgical Case Series (2023) (0)
- Reply to Ashish Chauhan. This letter to the Editor is in response to "Similar cure rates with different routes. Can it be generalized?"; manuscript reference #: GCH-D-22-02305. (2022) (0)
- Generation of immunoregulatory CD25+CD4+T cells following induction of oral tolerance (2001) (0)
- Intestinal Blautia may protect against neutropenic fever in allogeneic transplant patients by augmenting the intestinal epithelium. (2022) (0)
- RNA Sequencing of Intestinal Biopsies Expands the T Cell-Centric Paradigm of Steroid-Refractory Acute Graft-Versus-Host Disease (2019) (0)
- Salad/Vegetable Versus Red/Processed Meat-Dominant Diet And Outcomes of Hematopoietic Cell Transplantation (2021) (0)
- Risk Factors for Colonic Polyps in Patients with Cystic Fibrosis (2011) (0)
- Review Article Mast Cell Activation Disease and Microbiotic Interactions (2015) (0)
- Using Epidemiologic Evidence to Guide Recommendations for Colorectal Cancer Screening in Adults with Cystic Fibrosis (2017) (0)
- Fecal Microbiota Transplantation: An Interview With (2014) (0)
- 75200 Fecal Microbiota Transplantation to Prevent Infections in Patients with Acute Myeloid Leukemia: A Double-Blind Randomized Placebo-Controlled Phase 2 Clinical Trial (2021) (0)
- Human microbiome science (2014) (0)
- Impact of diet on hydrogen sulfide production: implications for gut health (2022) (0)
- How Painful is a Community Screening or Surveillance Colonoscopy?: 1360 (2011) (0)
- Esophageal Cancer in Patients With Cystic Fibrosis: 823 (2014) (0)
- Dysbiosis patterns during re-induction/salvage versus induction chemotherapy for acute leukemia (2019) (0)
- Lymphopenia Cell Repertoire during Reconstitution from Optimize Diversity of the Conventional T Regulatory T Cells + Foxp 3 + CD 25 + CD 4 Sing Way and (2010) (0)
- Preoperative Antibiotics Drive Short-Term Changes in the Gut Microbiome after Vertical Sleeve Gastrectomy (2016) (0)
- Su1961 – Cost-Effectiveness of Treatment Regimens for Clostridium Difficile Infection –An Evaluation of the 2018 Infectious Diseases Society of America Guidelines (2019) (0)
- CD4+CD25+Foxp3+ regulatory T cells maintain peripheral tolerance in the context of T cell LIP through preservation of TCR diversity (2008) (0)
- Sa1912 METHANOGEN ABUNDANCE THRESHOLDS DIFFERENTIATE METHANE AND NON-METHANE PRODUCERS (2020) (0)
- Interaction of gut microbiota with bile acid metabolism and its influence on disease states (2016) (0)
- Targeting the microbiome: from probiotics to fecal microbiota transplantation (2018) (0)
- 534 Systematic Colonoscopic Screening of Adults With Cystic Fibrosis Demonstrates High Incidence of Advanced Adenomatous Polyps (2013) (0)
- Psychological Features in the Inflammatory Bowel Disease–Irritable Bowel Syndrome Overlap: Developing a Preliminary Understanding of Cognitive and Behavioral Factors (2021) (0)
- Changes in microbial ecology after fecal microbiota transplantation for recurrent C. difficile infection affected by underlying inflammatory bowel disease (2017) (0)
- A Double-Blind Placebo-Controlled Trial of Fecal Microbiota Transplantation in Allogeneic Hematopoietic Cell Transplantation Recipients (2023) (0)
- Levaquin Gets a Pass (2020) (0)
- Pre-Transplant Fecal Microbiome Characteristics Are Associated with Subsequent Development of Chronic Graft-Versus-Host Disease (2022) (0)
- Shotgun sequencing of the faecal microbiome to predict response to steroids in patients with lower gastrointestinal acute graft‐versus‐host disease: An exploratory analysis (2020) (0)
- Immune Host Vivo That Is Imposed by Factors Present in Reduced Capacity for Clonal Expansion In Antigen-Experienced CD 4 T Cells Display a (2000) (0)
- Human microbiome science: vision for the future, Bethesda, MD, July 24 to 26, 2013 (2014) (0)
- Oral and gut microbiome alterations in heart failure: Epidemiology, pathogenesis and response to advanced heart failure therapies. (2022) (0)
- A dose-finding safety and feasibility study of oral activated charcoal and its effects on the gut microbiota in healthy volunteers not receiving antibiotics (2022) (0)
- The Use of Fecal Microbial Transplantation (FMT) and Pyrosequencing to Cure and Understand the Ecology of Clostridium difficile-associated Disease (2013) (0)
- Reply to: “ ‘You know my name, but not my story’ – Deciding on an accurate nomenclature for faecal microbiota transplantation” (2020) (0)
- ResponsivenessCycle Progression Promotes Recall Antigen Regulation of Clonal Anergy: Enhanced Cell Mammalian Target of Rapamycin in the Antagonistic Roles for CTLA-4 and the (2001) (0)
- Cell Repertoire during Reconstitution from Optimize Diversity of the Conventional T Regulatory T Cells + Foxp3 + CD25 + CD4 (2017) (0)
- Peripheral Tolerance T Cells Persist In Vivo Following Induction of + Direct Evidence That Functionally Impaired CD 4 Khoruts and (1998) (0)
- Sa569 PSYCHOSOCIAL FACTORS IN PATIENTS WITH CO-OCCURRING INFLAMMATORY BOWEL DISEASE AND IRRITABLE BOWEL SYNDROME (2021) (0)
- Gut Dysbiosis Increases Gut Barrier Damage during Anti-Leukemia Chemotherapy: Implications for Acute Graft-Versus-Host Disease (2019) (0)
- Transfer Therapy alters gut ecosystem and improves and autism symptoms: an open-label study. (2017) (0)
- Lymphopenia-Induced Proliferation of Naive Selectively Inhibit the Spontaneous Form of T Cells + Foxp 3 + CD 25 + Regulatory CD 4 Khoruts (2008) (0)
- Circulating Metabolomics Suggest Neutropenic Fever As a Metabolic Derangement Related to Intestinal Tissue Damage and Gut Dysbiosis (2021) (0)
- Compilation of longitudinal gut microbiome, serum metabolome, and clinical data in acute myeloid leukemia (2022) (0)
- Mo1290 Treatment of Urinary Tract Infections Without Affecting the Gut Microbiota in Patients With Recurrent Clostridium difficile Infection (2016) (0)
- lentiviral infections Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic (2013) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Alexander Khoruts?
Alexander Khoruts is affiliated with the following schools:
